Refractory Systemic Sclerosis
Immunology·MeSH: Scleroderma, Systemic
Prevalence
30.0 / 100K
0 drugs in development·0 companies·1 clinical trial
Frequently asked questions
How many clinical trials target Refractory Systemic Sclerosis?
There are 1 clinical trial targeting Refractory Systemic Sclerosis tracked by BioSniper.
What is the prevalence of Refractory Systemic Sclerosis?
The estimated prevalence of Refractory Systemic Sclerosis is approximately 30.0 per 100,000 population.
Deep-dive into Refractory Systemic Sclerosis
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis